- Effects of Concentrated Pomegranate Juice on Subclinical Inflammation and Cardiometabolic Risk Factors for Type 2 Diabetes: A Quasi-Experimental Study
Farideh Shishehbor et al, 2016, Int J Endocrinol Metab CrossRef - Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
Takayuki Fujimori et al, 2015, Oncol. Rep. CrossRef - Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro
LEI LI et al, 2015 CrossRef - Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells
GUOFANG CHEN et al, 2015 CrossRef - Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo
Hua-Qiang Zhu et al, 2016 CrossRef - Systematic review: Preventive and therapeutic applications of metformin in liver disease
Aparna Bhat, 2015, WJH CrossRef - Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I
Sunbin Ling et al, 2017, Cell Death Dis CrossRef - Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway.
Sunbin Ling et al, 2017, Int J Oncol CrossRef - Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma
KOJI HARADA et al, 2016 CrossRef - Chemoresistance and chemosensitization in cholangiocarcinoma.
Jose J G Marin et al, 2018, Biochim Biophys Acta Mol Basis Dis CrossRef - Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways
Claudia Fumarola et al, 2018, Biochemical Pharmacology CrossRef - Molecular bases of the poor response of liver cancer to chemotherapy.
Jose J G Marin et al, 2018, Clin Res Hepatol Gastroenterol CrossRef - Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway
Jaroon Wandee et al, 2018, Life Sciences CrossRef - Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells
Xilin Xiong et al, 2018, Biol Res CrossRef - A unified mitochondria mechanistic target of rapamycin acyl-coenzyme A dehydrogenase 10 signal relay modulation for metformin growth inhibition in human immortalized keratinocytes cells
Jiawen Wu et al, 2018, J Cell Biochem CrossRef - Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma
Jimin Dai et al, 2018, Cancer Med CrossRef - Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives.
Francesca Corti et al, 2019, Cancer Treat Rev CrossRef - mTOR Inhibitors in Advanced Biliary Tract Cancers
Chao-En Wu et al, 2019, IJMS CrossRef - Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
Xinqun Chai et al, 2015, Sci Rep CrossRef - Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
Floris H. Groenendijk et al, 2015, Int. J. Cancer CrossRef - Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPK
Tingting Feng et al, 2015, Biomedicine & Pharmacotherapy CrossRef - Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α
Hui Gao et al, 2015, Experimental Cell Research CrossRef - Current Insights on Cholangiocarcinoma Research: a Brief Review
Vivek Bhakta Mathema et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef - Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro
Xu Chen et al, 2015, Tumor Biol. CrossRef - Metformin influences progression in diabetic glioblastoma patients
Sebastian Adeberg et al, 2015, Strahlenther Onkol CrossRef - Synergistic therapeutic effects of Schiff's base cross-linked injectable hydrogels for local co-delivery of metformin and 5-fluorouracil in a mouse colon carcinoma model
Xilong Wu et al, 2016, Biomaterials CrossRef - Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
Sunbin Ling et al, 2017, J Hematol Oncol CrossRef - USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
Sunbin Ling et al, 2017, Mol Oncol CrossRef - null
Jose J.G. Marin et al, 2020 CrossRef - Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
Takuma Yamashita et al, 2020, Anti-Cancer Drugs CrossRef - Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
Jose J.G. Marin et al, 2020, Cells CrossRef - Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
Mirella Pastore et al, 2020, Cells CrossRef - Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil
Neslisah Barlak et al, 2020, CCAND CrossRef - Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
Wang Chengye et al, 2017, Oncotarget CrossRef - 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
Corti Denise et al, 2015, Oncotarget CrossRef - Sequence‑dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action
Abdulmajeed Bahman et al, 2018, Int J Mol Med CrossRef - Metformin synergizes with rapamycin to inhibit the growth of pancreatic cancer in vitro and in vivo.
Jia-Wei Zhang et al, 2018, Oncol Lett CrossRef - Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU
Jing Sang et al, 2020, BioMed Research International CrossRef - The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients
M. N. Yurova, 2020, Adv Gerontol CrossRef - Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication
Charupong Saengboonmee et al, 2020, Canadian Journal of Diabetes CrossRef - Nuclear Magnetic Resonance-Based Metabolomic Analysis of the Anticancer Effect of Metformin Treatment on Cholangiocarcinoma Cells
Jin Zhang et al, 2020, Front. Oncol. CrossRef - Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
Sabina Di Matteo et al, 2021, Sci Rep CrossRef - Repurposing metformin for the treatment of gastrointestinal cancer
Ademar Dantas Cunha Júnior et al, 2021, WJG CrossRef - Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
Jinqing Wu et al, 2021, Gastroenterology Research and Practice CrossRef - Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway
Jaroon Wandee et al, 2019, Life Sciences CrossRef - Effects of Metformin Combined With Antifolates on HepG2 Cell Metabolism and Cellular Proliferation
Sherouk M. Tawfik et al, 2022, Front. Oncol. CrossRef - The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Zhimin Tang et al, 2021, ACAMC CrossRef - Metabolic Reprogramming in Cholangiocarcinoma
Chiara Raggi et al, 2022, Journal of Hepatology CrossRef - Research progress of metformin in the treatment of liver fibrosis
Anqi Zhang et al, 2023, International Immunopharmacology CrossRef - Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Junhong Chen et al, 2023, Medicina CrossRef - Metformin: A potential adjunct for treatment of systemic mastocytosis
Joseph H. Butterfield et al, 2024, Journal of Allergy and Clinical Immunology: Global CrossRef